Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Boch · SciRah

Researcher profile · Semantic Scholar

T. Boch

Share profile

T. Boch — researcher profile on SciRah

h-index: 22
Works: 67
Citations: 2,333

Most-cited papers

Human haematopoietic stem cell lineage commitment is a continuous process
Lars Velten, S. Haas, S. Raffel, Sandra Blaszkiewicz +13 more
2017Nature Cell Biology824 citations Open access
Semantic Scholar
Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states
S. Triana, Dominik Vonficht, L. Jopp-Saile, S. Raffel +18 more
2021Nature Immunology155 citations Open access
Semantic Scholar
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure.
M. Mossner, J. Jann, Janina Wittig, F. Nolte +25 more
2016Blood125 citations
Semantic Scholar
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
Lars Velten, Benjamin A. Story, Pablo Hernández-Malmierca, S. Raffel +16 more
2018Nature Communications107 citations Open access
Semantic Scholar
Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
T. Boch, B. Spiess, O. Cornely, J. Vehreschild +19 more
2016Clinical Microbiology and Infection105 citations Open access
Semantic Scholar
Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients: Performance of Cytokines, Asp LFD, and Aspergillus PCR in Same Day Blood and Bronchoalveolar Lavage Samples
S. Heldt, J. Prattes, S. Eigl, B. Spiess +12 more
2018Journal of Infection102 citations Open access
Semantic Scholar
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
D. Michaeli, J. Michaeli, S. Albers, T. Boch +1 more
2023American Journal of Cardiovascular Drugs101 citations Open access
Semantic Scholar
Galactomannan testing and Aspergillus PCR in same‐day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis
S. Eigl, M. Hoenigl, B. Spiess, S. Heldt +10 more
2016Medical Mycology100 citations
Semantic Scholar
Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay with Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: a Multicenter Cohort Study.
J. Jenks, J. Prattes, Johanna Frank, B. Spiess +4 more
2020Clinical Infectious Diseases71 citations Open access
Semantic Scholar
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool
Pablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, H. Uckelmann +38 more
2022Cell Stem Cell66 citations Open access
Semantic Scholar
Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1‐3‐beta‐D‐glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study
T. Boch, M. Reinwald, B. Spiess, Tobias Liebregts +10 more
2018Journal of critical care51 citations
Semantic Scholar
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors
M. Reinwald, T. Boch, W. Hofmann, D. Buchheidt
2015Biomarker Insights45 citations Open access
Semantic Scholar
Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples
T. Boch, M. Reinwald, P. Postina, O. Cornely +16 more
2015Mycoses (Berlin)43 citations
Semantic Scholar
Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients
C. Henzler, T. Henzler, D. Buchheidt, J. Nance +14 more
2017Scientific Reports37 citations Open access
Semantic Scholar
Posttranscriptional regulation of c-Myc expression in adult murine HSCs during homeostasis and interferon-α-induced stress response.
A. Ehninger, T. Boch, H. Uckelmann, M. Essers +3 more
2014Blood36 citations Open access
Semantic Scholar
Socio-economic burden of disease: Survivorship costs for bladder cancer.
J. Michaeli, T. Boch, S. Albers, T. Michaeli +1 more
2022Journal of Cancer Policy34 citations
Semantic Scholar
Loss of SPARC protects hematopoietic stem cells from chemotherapy toxicity by accelerating their return to quiescence.
A. Ehninger, T. Boch, H. Medyouf, K. Müdder +2 more
2014Blood33 citations
Semantic Scholar
Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients
P. Postina, J. Skladny, T. Boch, O. Cornely +10 more
2018Frontiers in Microbiology30 citations Open access
Semantic Scholar
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
T. Boch, Jens Köhler, M. Janning, S. Loges
2022Cancer Biology and Medicine29 citations Open access
Semantic Scholar
Comparison of extraction methods for intracellular metabolomics of human tissues
Carolin Andresen, T. Boch, H. Gegner, Nils Mechtel +7 more
2022Frontiers in Molecular Biosciences28 citations Open access
Semantic Scholar
Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis
T. Boch, D. Buchheidt, B. Spiess, T. Miethke +2 more
2016Mycoses (Berlin)27 citations
Semantic Scholar
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
D. Michaeli, J. Michaeli, T. Boch, T. Michaeli
2022Cardiovascular Drugs and Therapy23 citations Open access
Semantic Scholar
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
D. Michaeli, J. Michaeli, T. Boch, T. Michaeli
2022Clinical drug investigation20 citations Open access
Semantic Scholar
The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses
D. Buchheidt, M. Reinwald, M. Hoenigl, W. Hofmann +2 more
2017Current Opinion in Infectious Diseases18 citations
Semantic Scholar
Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery.
T. Boch, N. Frost, Linna Sommer, T. Overbeck +12 more
2021Lung Cancer15 citations
Semantic Scholar
Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis
T. Boch, B. Spiess, W. Heinz, O. Cornely +12 more
2019Mycoses (Berlin)15 citations Open access
Semantic Scholar
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS.
T. Boch, T. Luft, G. Metzgeroth, M. Mossner +11 more
2017Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis15 citations
Semantic Scholar
Evaluating the use of PCR for diagnosing invasive aspergillosis
D. Buchheidt, M. Reinwald, W. Hofmann, T. Boch +1 more
2017Expert Review of Molecular Diagnostics14 citations
Semantic Scholar
Biomarker‐based diagnostic work‐up of invasive pulmonary aspergillosis in immunocompromised paediatric patients – is Aspergillus PCR appropriate?
D. Buchheidt, M. Reinwald, B. Spiess, T. Boch +3 more
2016Mycoses (Berlin)14 citations
Semantic Scholar
Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects
F. Nolte, M. Mossner, J. Jann, D. Nowak +4 more
2017European Journal of Haematology10 citations
Semantic Scholar
High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes
V. Riabov, M. Mossner, A. Stöhr, J. Jann +20 more
2021British Journal of Haematology9 citations Open access
Semantic Scholar
Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab
D. Michaeli, J. Michaeli, T. Boch, T. Michaeli
2022European Heart Journal8 citations
Semantic Scholar
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
N. Schmitt, J. Jann, E. Altrock, J. Flach +23 more
2021Leukemia8 citations Open access
Semantic Scholar
Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
A. Radujkovic, T. Boch, F. Nolte, D. Nowak +6 more
2020Cancers4 citations Open access
Semantic Scholar
Socio-economic burden of disease: Survivorship costs for renal cell carcinoma.
J. Michaeli, D. Michaeli, T. Boch, S. Albers +1 more
2022European Journal of Cancer Care3 citations Open access
Semantic Scholar
Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
D. Michaeli, J. Michaeli, T. Boch, T. Michaeli
2022European Heart Journal2 citations
Semantic Scholar
S120: ACUTE MYELOID LEUKEMIA REPRESENTS A FERROPTOSIS-SENSITIVE CANCER ENTITY RAISING THE POSSIBILITY FOR NOVEL TARGETING STRATEGIES
A. Narr, H. Alborzinia, E. Donato, F. Vogel +6 more
2022HemaSphere2 citations Open access
Semantic Scholar
The Bone Marrow Microenvironment of Multiple Myeloma Long-Term Survivors at Single Cell Resolution
R. Lutz, A. Mahmoud, Mohamed H. S. Awwad, C. Imbusch +9 more
20202 citations Open access
Semantic Scholar
Safety and Efficacy of the CD95-Ligand Inhibitor APG101 in Transfusion-Dependent Patients with Low Risk MDS: Results from a Phase I Study
T. Boch, T. Luft, M. Mossner, J. Jann +8 more
20162 citations
Semantic Scholar
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms
A. Streuer, J. Jann, T. Boch, M. Mossner +17 more
2024Annals of Hematology1 citations Open access
Semantic Scholar
Understanding iron homeostasis in MDS: the role of erythroferrone
M. Abba, V. Riabov, D. Nowak, W. Hofmann +1 more
2024Frontiers in Oncology1 citations Open access
Semantic Scholar
874P The economic burden of surviving malignant melanoma
D. Michaeli, J. Michaeli, T. Boch, S. Albers +1 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
Direct Comparison of NSG and NBSGW Mice for MDS Patient-Derived Xenograft Models
N. Schmitt, A. Streuer, J. Danner, E. Altrock +15 more
2022Blood1 citations Open access
Semantic Scholar
Comparison of extraction methods for intracellular metabolomics
Carolin Andresen, T. Boch, H. Gegner, Nils Mechtel +7 more
2021bioRxiv1 citations Open access
Semantic Scholar
Session
I. Zeller, I. Kröckel, K. Kovač, B. Steinlechner +18 more
2019Mycoses (Berlin)1 citations Open access
Semantic Scholar
Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis
T. Boch, B. Spiess, O. Cornely, W. Heinz +6 more
20151 citations Open access
Semantic Scholar
Abstract: Multistage Registration of CT and Biopsy CT Images of Lung Tumors
Anika Strittmatter, Alexander Hertel, Steffen Diehl, M. Froelich +7 more
2024Bildverarbeitung für die Medizin0 citations Open access
Semantic Scholar
S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
M. Hartmann, M. Schönung, J. Rajak, Joschka Hey +30 more
2023HemaSphere0 citations Open access
Semantic Scholar
80P Efficacy, FDA approval, innovativeness, clinical evidence, and price of breast, ovarian, endometrial, and cervical cancer drugs
J. Michaeli, T. Michaeli, S. Albers, T. Boch +1 more
2023ESMO Open0 citations Open access
Semantic Scholar
Clinical evidence and benefit of special FDA designations in anti-cancer drugs.
D. Michaeli, J. Michaeli, S. Albers, T. Boch +2 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Hofmann×23
Invite
W. Hofmann — researcher profile on SciRah
D. Buchheidt×16
Invite
D. Buchheidt — researcher profile on SciRah
B. Spiess×14
Invite
B. Spiess — researcher profile on SciRah
M. Reinwald×13
Invite
M. Reinwald — researcher profile on SciRah

×12

Invite

D. Nowak — researcher profile on SciRah

Invite

A. Trumpp — researcher profile on SciRah

D. Michaeli×10

Invite

D. Michaeli — researcher profile on SciRah

J. Michaeli×10

Invite

J. Michaeli — researcher profile on SciRah

Invite

J. Jann — researcher profile on SciRah

Invite

F. Nolte — researcher profile on SciRah

Invite

M. Mossner — researcher profile on SciRah

G. Metzgeroth×7

Invite

G. Metzgeroth — researcher profile on SciRah